Search results for: England
Filter search results
OHE is Pleased to Host Four MSc Students for 2016
26 July 2016
…health care provided in England. In recent decades, patient-reported satisfaction with services has been seen as an increasingly important indicator of the quality of health care. Patients’ experience is hypothesised…
New Member of the EuroQol Group: OHE’s Dr Yan Feng
6 March 2017
…the EQ-5D in England, in collaboration with Professor Hugh Gravelle (University of York) and Professor Nancy Devlin; Exploring the inconsistent ordering of the EQ-5D-5L value set, in collaboration with Professor…
Important Variations in Access to Orphan Drugs in France, Italy, Germany, Spain and the UK
14 March 2017
…that compares the availability of and access to orphan medicinal products (OMPs) in the UK (England, Scotland and Wales), France, Germany, Italy and Spain. The analysis quantifies the availability, access and the time…
The Long-term Sustainability of the NHS and Adult Social Care
13 April 2017
…achieving this goal and that with this focus there is no need for NHS England and NHS Improvement to co-exist. Thus, they conclude that the two should be merged to…
Making Outcome-based Payments a Reality in the NHS: A Research Collaboration between OHE, RAND Europe and King’s College London
15 May 2018
…they achieve? This question was raised by Cancer Research UK, in a Research Brief (PDF), as a potential way of addressing the challenges faced by health care in England, including…
Recommendations for Making Outcome-based Payments a Reality in the NHS: An Application to Cancer Drugs
21 February 2019
…has just been published and can be found here. The research team explored the current funding landscape in England, with a focus on the role of patient outcomes in the…
HTA and Payment Mechanisms for New Drugs to Tackle AMR
23 September 2019
…as demonstrated by important policy measures that have been put in place to address AMR. In England for example, NICE and NHS England have recently announced a pilot programme of…
NICE and EuroQol Research Foundation to Support New EQ-5D-5L Valuation Study
24 October 2019
…set for England untenable. It’s time to move forward. There are some things that all parties (mostly) agree on: The EQ-5D-5L is a superior descriptive system to the EQ-5D-3L, but…
Cost-Effectiveness Thresholds and Expert Elicitation: a Bridge Too Far?
29 April 2021
…In England, if the price and effectiveness of a new technology reviewed by the National Institute for Health and Care Excellence (NICE) means the NHS pays less than a threshold…